Please ensure Javascript is enabled for purposes of website accessibility

Why GenMark Diagnostics Stock Is Soaring Today

By Keith Speights - Updated Feb 11, 2021 at 11:57AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company could be a potential acquisition target.

What happened

Shares of GenMark Diagnostics (GNMK) were soaring 34.8% higher as of 11:43 a.m. EST on Thursday. The big jump came after Bloomberg reported that the diagnostics company could be acquired.

So what

Bloomberg's report stated that GenMark has been contacted by multiple potential buyers. The company is said to have engaged a financial advisor to help it navigate acquisition discussions. GenMark hasn't made any public statements about the report at this point.

Woman drawing a picture on a wall of a big fish about to swallow a smaller fish

Image source: Getty Images.

Investors shouldn't buy the healthcare stock solely because of the possibility that it might be acquired. These kinds of stories often fizzle out. 

However, GenMark looks like a pretty good buyout target for a bigger diagnostics company. It wouldn't be surprising if Becton Dickinson, Thermo Fisher Scientific, or Roche is interested in acquiring GenMark. 

Now what

It's now a waiting game to see if a deal emerges. And if there is a deal, the details will be important. An offer price might not be much more than GenMark's current share price after its big move today. 

Keith Speights has no position in any of the stocks mentioned. The Motley Fool recommends Becton, Dickinson. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

GenMark Diagnostics, Inc. Stock Quote
GenMark Diagnostics, Inc.
Roche Holding AG Stock Quote
Roche Holding AG
$41.36 (0.49%) $0.20
Becton, Dickinson and Company Stock Quote
Becton, Dickinson and Company
$255.97 (0.68%) $1.74
Thermo Fisher Scientific Inc. Stock Quote
Thermo Fisher Scientific Inc.
$583.95 (-1.07%) $-6.31

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/09/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.